Sh. Pincus et al., INTERACTION OF GROUP-B STREPTOCOCCAL OPACITY VARIANTS WITH THE HOST-DEFENSE SYSTEM, Infection and immunity, 61(9), 1993, pp. 3761-3768
Group B streptococci (GBS) demonstrate high-frequency phase variation
of colony opacity. Colony opacity is a function of chain length, with
opaque colonies consisting of GBS that form longer chains. Because opa
que variants do not grow on standard streptococcal media, the role of
opacity variation in GBS infection has not been studied. We have isola
ted stable variants from type III GBS that are either transparent (var
iants 1.2 and 1.3) or opaque (variants 1.1 and 1.5). In this study, we
evaluated the interactions of these variants with different component
s of the host immune system both in vitro and in vivo. Opaque GBS were
less immunogenic than transparent GBS. Opaque GBS were more susceptib
le to killing by polymorphonuclear neutrophils (PMNs) and could induce
a chemiluminescent response of PMNs in the absence of antibody (Ab) o
r complement. Transparent GBS did not induce neutrophil chemiluminesce
nce in the absence of Ab and complement. However, in the presence of A
b and complement, transparent GBS induced a stronger chemiluminescent
response than did opaque GBS. Scanning electron micrographs of PMNs an
d GBS demonstrated differences in the attachment and engulfment of the
different variants by the PMNs as well as different effects of the GB
S on the PMNs themselves. Interactions with complement were affected b
y GBS opacity as well, with opaque variant 1.1 initiating complement a
ctivation in the absence of any Ab. The virulence of the GBS opacity v
ariants was studied in vivo by inoculation of graded numbers of GBS in
to newborn mice. Transparent variants 1.2 and 1.3 were most virulent,
with variant 1.1 intermediate and variant 1.5 minimally virulent. Howe
ver, in mixed infections, variant 1.5 greatly enhanced the virulence o
f small numbers of transparent GBS. These results indicate that the op
acity status of GBS can influence the interaction between the GBS and
the host immune system.